<DOC>
	<DOC>NCT00418730</DOC>
	<brief_summary>The purpose of this study is to measure the hair growth response to topical NEOSH101 when applied twice daily to the balding scalp for 16 weeks. One hundred eighty men with Norwood/Hamilton grades III-IV with thinning in the top and center of the scalp will participate. Three equally sized treatment groups (60 men each) will receive either topical NEOSH101 2.0%, minoxidil 5%, or placebo.</brief_summary>
	<brief_title>Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Proteasome Inhibitors</mesh_term>
	<criteria>Caucasian men, in general good health, aged 1849 years Norwood/Hamilton grades IIIIV, with thinning hair in the vertex area concomitant dermatologic or medical condition(s) which may interfere with the investigator's ability to evaluate the subject's response to the study drug treatment with a systemic or locally acting medication which may interfere with the study objectives, such as minoxidil treatment in the 6 months prior to study start, finasteride treatment in the 12 months prior to study start, or treatment with other investigational hair growth products in the 6 months prior to study start</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>androgenetic alopecia</keyword>
	<keyword>male pattern hair loss</keyword>
	<keyword>male pattern baldness</keyword>
	<keyword>androgenetic alopecia or male pattern hair loss</keyword>
</DOC>